{"name":"NexEos Diagnostics, Inc.","slug":"nexeos-diagnostics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNd1BMS2MzaTRNUlJKT2NhUzVBQ19RNkhMLW5wUV94VjJOQ0dfSk1DS3RnQWVMd0xOcllfYUR1aVBKOVMyTWxGX29UQjNmanUtN0ZnYmt2YkVTODZ0elB3ZmZ1TUZIZFhzVnB2c1U3SnpZV0dNOTdTR0VRTEtHTEZRVlJCLVp3SGFaT2dGUDNfS1NGS1FCaDdETnQwbWxRM1cxX0wzaFIxWVExbWFuU2xF?oc=5","date":"2024-05-15","type":"pipeline","source":"The Business Journals","summary":"Uniquity Bio emerges from stealth mode with up to $300M from Blackstone - The Business Journals","headline":"Uniquity Bio emerges from stealth mode with up to $300M from Blackstone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNS08wb001ME1uY2JCZ05YeEdmY0JBSjdRczROeF83U29GT2luUzBwZDVidWJUYTJ1RVItNmtXNGFWcFNRY3pYS1N5emc1S0EySGItMzBVSXowaG9GMUJ1VnpfMTBRcmNRdGhSWUVrOWRaSFNlcXhpbEM3VDFYYnNaUXZjYVBRMlNTbFpNUHlnMzNrTm5MTGc?oc=5","date":"2023-09-28","type":"pipeline","source":"Yahoo Finance","summary":"Eosinophilic Esophagitis Market to Show Positive Growth by 2032, Examines DelveInsight | Key Companies - Bristol Myers Squibb, Ellodi, AstraZeneca, Kyowa Kirin, Allakos, Pfizer, Revolo, EsoCap AG, Nex","headline":"Eosinophilic Esophagitis Market to Show Positive Growth by 2032, Examines DelveInsight | Key Companies - Bristol Myers S","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}